Fracture prevalence in thalassemia: a systematic review and meta-analysis
- PMID: 34773506
- DOI: 10.1007/s11657-021-01026-0
Fracture prevalence in thalassemia: a systematic review and meta-analysis
Abstract
Background: Multiple observational studies have reported high prevalence of fracture in patients with thalassemia. However, most of these studies have included limited number of patients, and only few of them have reported prevalence of fracture among patients with different types and severity of thalassemia.
Objective: This systematic review and meta-analysis was conducted to summarize all available data of fracture prevalence among patients with thalassemia.
Methods: A systematic review was conducted using EMBASE and MEDLINE databases from inception to June 2021 to determine studies that reported prevalence of fracture in thalassemia patients. The pooled prevalence with 95% confidence interval (95%CI) of fracture across studies was determined using a random-effect, generic inverse variance method.
Results: After two rounds of systematic review, a total of 25 studies with 4934 patients were included in the meta-analysis. The pooled prevalence of fracture among patients with thalassemia was 16% (95%CI, 15-17%, I2 = 94.3%). The subgroup analyses showed that the pooled prevalence of fracture was 4% (95%CI, 2-6%; I2 = 70.4%) among patients with alpha thalassemia, 17% (95%CI, 16-19%; I2 = 93.2%) among patients with beta thalassemia, 18% (95%CI, 16-19%; I2 = 89.0%) among patients with transfusion-dependent thalassemia, and 7% (95%CI, 4-10%; I2 = 94.2%) among patients with non-transfusion-dependent thalassemia.
Conclusion: Fracture is common in patients with thalassemia, and may be more prevalent in beta thalassemia and transfusion-dependent thalassemia than in alpha thalassemia and non-transfusion-dependent thalassemia.
Keywords: Fracture; Meta-analysis; Systematic review; Thalassemia.
© 2021. International Osteoporosis Foundation and National Osteoporosis Foundation.
Similar articles
-
Clinical effectiveness and cost-effectiveness of bone morphogenetic proteins in the non-healing of fractures and spinal fusion: a systematic review.Health Technol Assess. 2007 Aug;11(30):1-150, iii-iv. doi: 10.3310/hta11300. Health Technol Assess. 2007. PMID: 17669279
-
Electronic cigarettes for smoking cessation.Cochrane Database Syst Rev. 2021 Sep 14;9(9):CD010216. doi: 10.1002/14651858.CD010216.pub6. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2022 Nov 17;11:CD010216. doi: 10.1002/14651858.CD010216.pub7. PMID: 34519354 Free PMC article. Updated.
-
Gestational weight gain below instead of within the guidelines per class of maternal obesity: a systematic review and meta-analysis of obstetrical and neonatal outcomes.Am J Obstet Gynecol MFM. 2022 Sep;4(5):100682. doi: 10.1016/j.ajogmf.2022.100682. Epub 2022 Jun 18. Am J Obstet Gynecol MFM. 2022. PMID: 35728780
-
Home treatment for mental health problems: a systematic review.Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150. Health Technol Assess. 2001. PMID: 11532236
-
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2. Cochrane Database Syst Rev. 2022. PMID: 36161421 Free PMC article.
Cited by
-
Recent advancements in glucose dysregulation and pharmacological management of osteoporosis in transfusion-dependent thalassemia (TDT): an update of ICET-A (International Network of Clinicians for Endocrinopathies in Thalassemia and Adolescence Medicine).Acta Biomed. 2023 Jun 14;94(3):e2023178. doi: 10.23750/abm.v94i3.14805. Acta Biomed. 2023. PMID: 37326257 Free PMC article. Review.
-
Non-Transfusion-Dependent Thalassemia: A Panoramic Review.Medicina (Kaunas). 2022 Oct 21;58(10):1496. doi: 10.3390/medicina58101496. Medicina (Kaunas). 2022. PMID: 36295656 Free PMC article. Review.
-
Current issues in evaluation and management of osteoporosis in Thailand.Osteoporos Sarcopenia. 2023 Jun;9(2):53-59. doi: 10.1016/j.afos.2023.05.002. Epub 2023 Jun 27. Osteoporos Sarcopenia. 2023. PMID: 37496986 Free PMC article. Review.
-
New Entity-Thalassemic Endocrine Disease: Major Beta-Thalassemia and Endocrine Involvement.Diagnostics (Basel). 2022 Aug 9;12(8):1921. doi: 10.3390/diagnostics12081921. Diagnostics (Basel). 2022. PMID: 36010271 Free PMC article. Review.
-
Analysis of circRNAs and circRNA-associated competing endogenous RNA networks in β-thalassemia.Sci Rep. 2022 May 16;12(1):8071. doi: 10.1038/s41598-022-12002-0. Sci Rep. 2022. PMID: 35577924 Free PMC article.
References
-
- Cao A, Galanello R (2010) Beta-thalassemia. Genet Med 12(2):61–76. https://doi.org/10.1097/GIM.0b013e3181cd68ed - DOI - PubMed
-
- Weatherall DJ (2015) The thalassemias: disorders of globin synthesis. In: Kaushansky K, Prchal JT, Press OW et al (eds) Williams Hematology, 9th edn. McGraw-Hill Education, USA, pp 725–758
-
- Sleiman J, Tarhini A, Bou-Fakhredin R, Saliba AN, Cappellini MD, Taher AT (2018) Non-transfusion-dependent thalassemia: an update on complications and management. Int J Mol Sci 19(1):182. https://doi.org/10.3390/ijms19010182 - DOI - PMC
-
- Taher AT (2017) Saliba AN (2017) Iron overload in thalassemia: different organs at different rates. Hematology 1:265–271. https://doi.org/10.1182/asheducation-2017.1.265 - DOI
-
- Saliba AN, Taher AT (2016) Morbidities in non-transfusion-dependent thalassemia. Ann N Y Acad Sci 1368(1):82–94. https://doi.org/10.1111/nyas.13083 - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical